NCT06619613View on ClinicalTrials.gov

A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Alzheimer Disease
Interventions
BIOLOGICAL

Alzheimer Disease (AD)

CM383 injection

OTHER

Placebo

Matched placebo

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of University of Science and Technology of China, Hefei

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06619613 - A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease | Biotech Hunter | Biotech Hunter